Home/Filings/4/0001209191-22-036386
4//SEC Filing

du Toit Michael 4

Accession 0001209191-22-036386

CIK 0001337553other

Filed

Jun 12, 8:00 PM ET

Accepted

Jun 13, 5:10 PM ET

Size

7.3 KB

Accession

0001209191-22-036386

Insider Transaction Report

Form 4
Period: 2022-06-09
Transactions
  • Award

    Common Stock

    2022-06-09+6,24516,095 total
  • Award

    Stock Option (right to buy)

    2022-06-09+16,85416,854 total
    Exercise: $6.11Exp: 2032-06-09Common Stock (16,854 underlying)
Footnotes (2)
  • [F1]Subject to the reporting person's continued service on the board of directors of the issuer through the vesting date, these shares of Common Stock are scheduled to vest on June 9, 2023.
  • [F2]Subject to the reporting person's continued service on the board of directors of the issuer through the applicable vesting date, this option is scheduled to vest ratably on each of the first 12 monthly anniversaries of June 9, 2022.

Issuer

AERIE PHARMACEUTICALS INC

CIK 0001337553

Entity typeother

Related Parties

1
  • filerCIK 0001633208

Filing Metadata

Form type
4
Filed
Jun 12, 8:00 PM ET
Accepted
Jun 13, 5:10 PM ET
Size
7.3 KB